Geng Xu

749 total citations
50 papers, 585 citations indexed

About

Geng Xu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Geng Xu has authored 50 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Geng Xu's work include Allergic Rhinitis and Sensitization (5 papers), Glioma Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Geng Xu is often cited by papers focused on Allergic Rhinitis and Sensitization (5 papers), Glioma Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Geng Xu collaborates with scholars based in China, Italy and Netherlands. Geng Xu's co-authors include Lin Q, Feng Ling, Elisa Giovannetti, Zhao Liu, Jianbo Shi, Fenghong Chen, Huabin Li, Yihua Wu, Qing Luo and Dehua Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Physical Review B.

In The Last Decade

Geng Xu

44 papers receiving 579 citations

Peers

Countries citing papers authored by Geng Xu

Since Specialization

Citations

This map shows the geographic impact of Geng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geng Xu more than expected).

Fields of papers citing papers by Geng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geng Xu. The network helps show where Geng Xu may publish in the future.

Co-authorship network of co-authors of Geng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Geng Xu. A scholar is included among the top collaborators of Geng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geng Xu. Geng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of Oral Bacteria in Mediating Gemcitabine Resistance in Pancreatic Cancer 2025 ·Biomolecules ·Geng Xu, (unknown), (unknown), Bernd W. Brandt, Kamran Nazmi, Luca Morelli, (unknown), Elisa Giovannetti, Dongmei Deng	0
2	The Oral Microbiome and Cancer 2025 ·Advances in experimental medicine and biology ·Juan Deng, Chen Sun, Geng Xu, (unknown), (unknown), Dongmei Deng, Elisa Giovannetti	3
3	Ibrutinib combined with rituximab and high-dose methotrexate in newly diagnosed primary CNS diffuse large B-cell lymphoma: a pilot study with long-term follow-up 2025 ·Frontiers in Oncology ·(unknown), Yongzhi Shan, Yueshan Piao, Xiaoli Chang, Dongmei Zou, Qiang Ma, Yukui Wei, Geng Xu, Yaming Wang, Dandan Wang, Lianghong Teng, Chunxue Wu, Zhilian Zhao, Tianbin Song, (unknown), (unknown), Li Su, Wanling Sun	0
4	HSP90 inhibition reverses resistance to TRAIL-induced apoptosis in non-small cell lung cancer cells 2025 ·SHILAP Revista de lepidopterología ·Kaamar Azijli, Geng Xu, (unknown), (unknown), Shiv Pillai, Sjors M. Kas, Antonio Russo, Elisa Giovannetti, Steven de Jong, Godefridus J. Peters, Frank A.E. Kruyt	0
5	Ibrutinib, Rituximab, and High-Dose Methotrexate in Newly Diagnosed Primary Diffuse Large B-Cell Lymphoma of the CNS: A Prospective, Phase II, Single-Arm, Single-Center Study 2024 ·Blood ·(unknown), Yongzhi Shan, (unknown), Xiaoli Chang, Dongmei Zou, Qiang Ma, Yukui Wei, Geng Xu, Yaming Wang, Jie Tang, Dandan Wang, Lianghong Teng, Chunxue Wu, Zhilian Zhao, Tianbin Song, (unknown), (unknown), Li Su, Wanling Sun	1
6	Synthesis and biological evaluation of a new class of azole urea compounds as Akt inhibitors with promising anticancer activity in pancreatic cancer models 2024 ·Bioorganic Chemistry ·Camilla Pecoraro, (unknown), Daniela Carbone, Geng Xu, Juan Deng, Stella Cascioferro, Elisa Giovannetti, Patrizia Diana, (unknown)	3
7	Targeting a key FAK-tor: the therapeutic potential of combining focal adhesion kinase (FAK) inhibitors and chemotherapy for chemoresistant non-small cell lung cancer 2024 ·Expert Opinion on Investigational Drugs ·(unknown), (unknown), Godefridus J. Peters, Dongmei Deng, Patrizia Diana, Elisa Giovannetti, Geng Xu	2
8	Single-Cell RNA-Seq Analysis of Hearts in Patients with Fetal Tetralogy of Fallot 2024 ·Cardiology ·(unknown), Jingai Zhu, Geng Xu, Qing Cheng, Chun Zhu	1
9	Doppler Echocardiography Combined with NTproBNP/BNP in the Diagnosis of Pulmonary Artery Hypertension Associated with Congenital Heart Disease 2023 ·Computational and Mathematical Methods in Medicine ·Xi Zhang, (unknown), Geng Xu, Yanbo Zhu, (unknown), Tongyun Chen, (unknown), Jingkun Zhang, Zhigang Guo, (unknown)	0
10	Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance 2022 ·Drug Resistance Updates ·Mjriam Capula, Macarena Perán, Geng Xu, Valentina Donati, (unknown), (unknown), Yehuda G. Assaraf, Elisa Giovannetti, Dongmei Deng	38
11	Synthesis and in vivo evaluation of new steviol derivatives that protect against cardiomyopathy by inhibiting ferroptosis 2022 ·Bioorganic Chemistry ·Chao Xu, (unknown), Zhiyin Li, Zhen‐Yu Chen, Qi Jia, (unknown), Liping Luo, Geng Xu, (unknown), Zhengqiang Yuan, Yu Zhao	8
12	Glioma Imaging by O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Diffusion-Weighted MRI and Correlation With Molecular Phenotypes, Validated by PET/MR-Guided Biopsies 2021 ·Frontiers in Oncology ·Ye Cheng, Shuangshuang Song, Yukui Wei, Geng Xu, Yang An, Jie Ma, Hongwei Yang, Zhigang Qi, Xinru Xiao, Jie Bai, (unknown), (unknown), Tingting Sun, Leiming Wang, Jie Lu, Lin Q	9
13	Synthesis and in vivo screening of isosteviol derivatives as new cardioprotective agents 2021 ·European Journal of Medicinal Chemistry ·Hanyuan Zhang, Bo Liu, Geng Xu, Chao Xu, (unknown), (unknown), Xiaoou Sun, Yu Zhao	14
14	Increased carotid stiffness detected by ultrafast ultrasound imaging is associated with the Gensini score 2020 ·Medical Ultrasonography ·Li Yang, Ying Zhang, Geng Xu, Shuai Zhao, (unknown), Yibin Wang	7
15	SOX2 has dual functions as a regulator in the progression of neuroendocrine prostate cancer 2019 ·Laboratory Investigation ·Haiying Li, Lili Wang, Zhang Li, Geng Xu, Ming Li, Qi Tang, Chunxiao Wu, Zhiming Lu	32
16	Extraction, Purification and Pharmacological Activity of Melon Pedicle Active Ingredients 2014 ·Asian Journal of Chemistry ·Geng Xu, (unknown), Fei Wang, Taowen Pan, Yun-Peng Diao, Yuan Lin	1
17	Diffusion tensor imaging correlates with subcortical stimulation for intraoperative pyramidal tract mapping: a preliminary study 2010 ·Zhonghua shenjing waike zazhi ·Fengping Zhu, Jinsong Wu, Chengjun Yao, Liqin Lang, Geng Xu, Jun Zhang, Liangfu Zhou	2
18	Synthesis and cytotoxicity of cis-dichloroplatinum (II) complexes of (1S,3S)-1,2,3,4-tetrahydroisoquinolines 2010 ·European Journal of Medicinal Chemistry ·Geng Xu, Yan Zheng, Nan Wang, Zhanzhu Liu	11
19	Parthenolide inhibits proliferation of vascular smooth muscle cells through induction of G0/G1 phase cell cycle arrest 2009 ·Journal of Zhejiang University SCIENCE B ·(unknown), Meihua Sui, Shan Chen, Jianan Wang, Geng Xu, (unknown), Shan Jiang, Lu Fang	14
20	Polymorphisms in the genes for coagulation factor II, V, VII in patients undergoing coronary angiography 2003 ·Journal of Zhejiang University. Science A ·Geng Xu, (unknown), Guosheng Fu, Ji Ma, (unknown), Jianan Wang	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact